During the hearing, counsel representing the High Court contended that the proposal for establishing a creche facility was under consideration and linked to ongoing construction plans within the ...

Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2025. [Operator Instructions] As a reminder, this conference is being recorded. It is ...

Geron Corporation (NASDAQ:GERN) Q4 2025 Earnings Call Transcript February 25, 2026 Geron Corporation misses on earnings ...

The Federal High Court, Lagos, has frozen the accounts linked to Petrocam Trading Nigeria Limited and its principal, Patrick Ilo, over an ...

Registrations To Open Soon, Exam On May 2The National Board of Examinations in Medical Sciences (NBEMS) will soon begin registration ...

Chief Executive Officer — Harout Semerjian Chief Commercial Officer — Ahmed ElNawawi Executive Vice President, Research and Development and Chief Medical Officer — Joseph Eid Chief Financial Officer — ...

The High Court set aside the Settlement Commission’s order rejecting a settlement application. It held that while non-cooperation was noted, the finding regarding lack of full disclosure lacked ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

To enable more accurate estimation of connectivity, we propose a data-driven and theoretically grounded framework for optimally designing perturbation inputs, based on formulating the neural model as ...

Rigel Pharmaceuticals (NASDAQ:RIGL) detailed record commercial performance for the fourth quarter and full year 2025, while outlining plans to pursue additional in-licensing opportunities and advance ...

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively Reported total operating expenses of $255 million for full year 2025, ...